Please login to the form below
AIDS
This page shows the latest AIDS news and features for those working in and with pharma, biotech and healthcare.
Merck KGaA, Pfizer’s Bavencio improves survival in bladder cancer
status. The updated overall survival data could help Bavencio extend into the first-line setting, which could aid sales growth of the drug in an area with tough competition.
Latest news
-
Wave’s challenge to Sarepta in Duchenne falls flat
These results are not what we expected, particularly given the promising data from our preclinical models, and we commit to further analysing and understanding the results to aid in future research,”
-
J&J appeals Oklahoma opioid verdict, claiming ‘errors’ in trial
Purdue has since filed for bankruptcy, and will aid in the formation of a new company, aptly named NewCo, which will be governed by a new board selected by the claimants
-
Sandoz expands into Japan with €400m Aspen deal
Japan’s generic medicines market is the third largest globally, a fact which will aid Sandoz’ continuing growth – in Novartis’ recent third quarter results, Sandoz brought in a hefty $2.5bn,
-
Harnessing the power of cultural insight to build meaningful healthcare strategies
This scenario is a prime example of how culture provides a broader context to our understanding and demonstrates how it is a powerful decision aid, even in the highly rational world
-
NICE International relaunches, will offer advisory services
Meets growing demand from global health and social care organisations. The National Institute for Health and Care Excellence (NICE) has relaunched its non-profit international division to aid with a growing
More from news
Approximately 15 fully matching, plus 621 partially matching documents found.
Latest Intelligence
-
Keeping up the fight against HIV and using the lessons to tackle other threats
Fatty liver disease is in its infancy and its malignancy is not threatening an epidemic on the scale of HIV/AIDS yet, but a co-ordinated response as it becomes more
-
Novel endpoints in the digital age
They could also aid in retaining patients in a trial if the novel endpoints reduce the burden on patients, compared to previously invasive endpoints. ... The EMA’s support is provided via its initiative for qualification of novel methodologies, which
-
Patient journey mapping: exploring the clinical and the emotional journey
The data immersion and bespoke market research used to better understand the psychological journey can aid identification of unmet needs, leverage key information points and assist in facilitating tactical solutions around
-
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D. All indications suggest biomarkers could aid cancer immunotherapy development and help doctors predict therapeutic impact. But industry still has to agree harmonised
-
The Cystic Fibrosis Buyers’ Club
HIV/AIDS and radical patient activists. The most energised and even radical patient activism has tended to occur in rare, life- threatening diseases – the most influential being the HIV/AIDS movement ... This movement spawned the AIDS Coalition to
More from intelligence
Approximately 2 fully matching, plus 69 partially matching documents found.
Latest appointments
-
New hires at bluebird bio, BioNTech and Provention Bio
In her new role, Heffron will be based in Zug, Switzerland, where she will aid the launch of bluebird’s first commercial product – its gene therapy Zynteglo.
-
Ashfield appoints new UK head of patient solutions
She has also worked with many key opinion leaders (KOLs) and facilitated advisory boards to aid the delivery of new models of patient care pathways, and was the winner of the
-
Faisal Ahmed joins healthcare comms agency Sudler London
He has also launched initiatives in healthcare, including iPad detail aids, mobile apps, artificial intelligence platforms and augmented reality apps.
-
Mundipharma appoints chief information officer
This approach will enable us to be more efficient and nimble, while ensuring the Mundipharma network continues to advance technology to aid in the development and commercialisation of medicines that address
-
Revolution Medicines appoints Dr Stephen Kelsey
aid cancer patients.
More from appointments
Approximately 1 fully matching, plus 21 partially matching documents found.
Latest from PMHub
-
It’s been altogether more magic for Lucid Group in 2019
Lucid SPIRIT, Lucid’s charity working group, has also kept very busy throughout 2019, running various fundraising events in aid of Wycombe Homeless Connection.
-
Frontera proud finalists for the 2020 PM Awards
Meanwhile, the agency’s extensive work across multiple Boehringer Ingelheim products including Pradaxa, Spiolto and OFEV were also recognised in Film &Animation (HCPs), Mixed Media Campaign and Sales Aid categories.
-
Making a difference with patient support
aid the use of a medical device.
-
WHITE PAPER: Patient nonadherence – the $637bn paradox
Diabetes Complications 1995; 9:81–86. 26. Kulcar Z. Self-help, mutual aid and chronic patients’ clubs in Croatia,.
-
RWE Blog 3: Is real-world evidence the holy grail
The value of RWE for payers therefore is as an aid to deeper understanding about what the product does in everyday use.
More from PMHub
Approximately 3 fully matching, plus 80 partially matching documents found.
Featured jobs
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Vice President
-
Competitive Salary Offered
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
- Account Director or Senior Account Director
-
Salary TBC
-
Consultant
-
competitive salary
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
Subscribe to our email news alerts
- Novartis gets EU approval for multiple sclerosis therapy Mayzent
- Moving annual total (MAT)
- Novartis links up with NHS for speedy access to cholesterol drug inclisiran
- Roche’s SMA treatment risdiplam hits another clinical target
- NICE knocks back AstraZeneca's Tagrisso again
- Lilly will aim for one $1bn-$5bn deal per quarter in 2020
- New coronavirus sees drug developers scramble to develop a vaccine
- Sanofi completes acquisition of immuno-oncology specialist Synthorx
- Roche's checkpoint inhibitor fails pivotal urothelial cancer trial
- Epizyme wins FDA approval for epithelioid sarcoma treatment
- Pharma Brand Planners' Blog (Part 8)
- Happy Chinese New Year 2020 - The Year of The Rat
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- Happy Chinese New Year 2020 - The Year of The Rat
- A fond farewell to The Year of the Pig...
- White Paper for download - Explaining the price of your product
- In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
- OPEN Health expands offering with the launch of a new Learning & Development specialist team
- Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Quick links
Infographics
